EUCTR2005-003701-91-IT进行中（未招募）不适用
ONCE WEEKLY DOSING OF DARBEPOETIN ALPHA AS PROPHYLACTIC TREATMENT FOR ANEMIA IN ELDERLY CANCER PATIENTS
ISTITUTO NAZIONALE PER LA CURA TUMORI0 个研究点开始时间: 2007年4月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Evaluation of the Efficacy of Darbepoetin Alfa for the Treatment of Anemia in Patients with Myelodysplastic Syndrome - DARB-MDSEUCTR2005-004737-17-ITAZIENDA OSPEDALIERA BIANCHI-MELACRINO-MORELLI54
已完成
不适用
ong-term usage of darbepoetin alpha in non-dialysis CKD patientson-dialysis CKDJPRN-UMIN000017252Kyowa Hakko Kirin Co., Ltd.3,000
已完成
不适用
The effect of intervention with darbepoetin alfa on progression of renal decline[chronic renal failure?] in renal anaemia patients with chronic kidney disease not on dialysis.renal anaemia patients with chronic kidney disease not on dialysisJPRN-UMIN000006963Division of Nephrology,Department of Internal Medicine,Juntendo University Faculty of Medicine200
已完成
3 期
Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney DiseaseChronic Kidney DiseaseAnemiaNCT00925587Amgen358
尚未招募
2 期
Phase II study of the addition of darbepoetin alfa (Aranesp) and pegfilgrastim (Neulasta) support for optimal dose-dense chemotherapy for early breast cancerCancer - BreastBreast CancerACTRN12605000731695Mater Adult hospital30